Multiplexed Molecular Diagnostics for Respiratory, Gastrointestinal, and Central Nervous System Infections.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27444411.
- Also identified by PMC identifier 5091344.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The development and implementation of highly multiplexed molecular diagnostic tests have allowed clinical microbiology laboratories to more rapidly and sensitively detect a variety of pathogens directly in clinical specimens. Current US Food and Drug Administration-approved multiplex panels target multiple different organisms simultaneously and can identify the most common pathogens implicated in respiratory viral, gastrointestinal, or central nervous system infections. This review summarizes the test characteristics of available assays, highlights the advantages and limitations of multiplex technology for infectious diseases, and discusses potential utilization of these new tests in clinical practice.
Medical subject headings
- Central Nervous System Infections
- Gastrointestinal Diseases
- Molecular Diagnostic Techniques
- Respiratory Tract Infections